Thursday, October 13, 2011

Q&A opportunity with FDA Commissioner Hamburg on Regulatory Science

Have you heard about Regulatory Science at the FDA but you are not sure what it means for your work?  We’re pleased to have FDA Commissioner Hamburg join us for a Q&A webinar on Regulatory Science Initiative ImplementationCome and learn more about how this effort could stimulate personalized medicine programs, develop medical countermeasures to protect threats to global security, and ensure agency capability to evaluate new, innovative technologies.In the recently released report from FDA titled Driving Biomedical Innovation: Initiatives toImprove Products for Patients, Commissioner Hamburg said, “ It is clear that our nation is at an important crossroads, where the science before us presents unprecedented opportunities to create new and better medical products and promote better health for the public.  But we must act now to capitalize on this groundbreaking science in order to bring safter and more effective treatments to American families and keep our position as the global leader in scientific innovation. “Be part of this important and unique opportunity to learn more about the FDA’s vital work, and participate in the discussion.  This webinar is open to anyone, so please share this with your networks. 

Monday, October 17, 2011, 2pm (Eastern)

Register Now for the FasterCures Webinar: (required).

 This Webinar is part of FasterCures’ Webinar Series on research and innovation in medical research.

No comments: